...
首页> 外文期刊>Child's nervous system: ChNS : official journal of the International Society for Pediatric Neurosurgery >Hydroxyapatite ceramic implants for cranioplasty in children: a retrospective evaluation of clinical outcome and osteointegration
【24h】

Hydroxyapatite ceramic implants for cranioplasty in children: a retrospective evaluation of clinical outcome and osteointegration

机译:儿童脑成形术的羟基磷灰石陶瓷植入物:回顾性评估临床结果和骨折

获取原文
获取原文并翻译 | 示例

摘要

Introduction Cranioplasty in children is a controversial and challenging issue, since there is still no consensus on the ideal material. Main problems in paediatric age are represented by the child's growing skull, the lower bone thickness and the high incidence of cerebrospinal fluid (CSF) disorders or brain swelling. Autologous bone is still considered the "gold standard". When it is not available, a wide range of alloplastic materials have been proposed. Hydroxyapatite, a ceramic-based derivative, bears a chemical composition very similar to the human natural bone, making this material a valuable alternative to other cranioplasty solutions. Methods All patients implanted with a custom-made porous hydroxyapatite device at Santobono-Pausilipon Hospital in Naples were retrospectively reviewed. A follow-up CT scan of the skull was performed from 1 up to 48 months postoperatively to document the bone ingrowth as well as the osteointegration process. The bone density was measured as according to the Hounsfield scale at the bone-implant interface. Results Between 2014 and 2018, 11 patients (7 males, 4 females) underwent cranioplasty with hydroxyapatite ceramic implants (HAP). Patients' age ranged between 3 and 16 years old. Initial aetiology was trauma in most cases. Two subjects were implanted with HAP as primary cranioplasty, 9 as revision surgery following previous cranioplasty failure. Sites of the cranial defect were unilateral fronto-temporo-parietal (N = 8), unilateral frontal (N = 1) and bifrontal (N = 2). Two patients with large bilateral defects received two prostheses. In one of these, the two prostheses were explanted and replaced with two back-up implants (accounting for a total of 15 implants in 11 patients). Osteointegration was measurable for 12 out of 15 implanted devices. The mean percentage was about 51%. There were six asymptomatic prosthesis fractures (40%), all occurring within 6 months from implant. In one case, the bifrontal prostheses were explanted and replaced. This was the only patient who underwent revision surgery. Conclusion Hydroxyapatite ceramic implants represent a valid alternative to other cranioplasty solutions. Where coaptation occurs correctly, with good osteointegration, implant mechanical resistance increases over time.
机译:儿童的颅骨成形术是一个有争议的和挑战性的问题,因为仍然没有对理想的材料共识。儿科时代的主要问题是儿童种植的头骨,骨厚度下降和脑脊液(CSF)疾病或脑肿胀的高发病率。自体骨仍被认为是“金标准”。当不可用时,已经提出了广泛的所有塑料材料。羟基磷灰石是一种基于陶瓷的衍生物,具有与人类天然骨骼非常相似的化学组成,使该材料成为其他颅骨成形术溶液的有价值的替代品。方法回顾性审查在那不勒斯的Santobono-Pausilipon医院植入定制多孔羟基磷灰石装置的所有患者。颅骨的后续CT扫描术后1至48个月进行,以记录骨骼向内的骨骼和骨翘曲过程。根据骨刻界面处的Hounsfield刻度测量骨密度。结果2014年和2018年,11名患者(7名男性,4名女性)接受了羟基磷灰石陶瓷植入物(HAP)的颅骨成形术。患者的年龄在3到16岁之间。在大多数情况下,初始缓解学是创伤。将两个受试者植入HAP作为原发性颅骨成形术,9作为先前颅骨成形术失败后的修正手术。颅骨缺陷的遗址是单侧前颞 - 椎管(n = 8),单侧额额(n = 1)和双甲醛(n = 2)。两种患有大双侧缺陷的患者接受了两个假体。在其中之一中,介绍了两种假体,并用两个备用植入物(占11例患者共计15种植入物)取代。在15个植入设备中有12个,骨核对元件可测量。平均百分比约为51%。患有六种无症状假体骨折(40%),植入物的6个月内发生。在一个情况下,突出和更换了双抗体假体。这是唯一接受修订手术的患者。结论羟基磷灰石陶瓷植入物代表其他颅骨成形术溶液的有效替代品。如果辅助正确发生,并且具有良好的骨整折,植入机械电阻随着时间的推移而增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号